Literature DB >> 14711393

A dual luciferase multiplexed high-throughput screening platform for protein-protein interactions.

Bart W Nieuwenhuijsen1, Youping Huang, Yuren Wang, Fernando Ramirez, Gary Kalgaonkar, Kathleen H Young.   

Abstract

To study the biology of regulators of G-protein signaling (RGS) proteins and to facilitate the identification of small molecule modulators of RGS proteins, the authors recently developed an advanced yeast 2-hybrid (YTH) assay format for GalphaZ and RGS-Z1. Moreover, they describe the development of a multiplexed luciferase-based assay that has been successfully adapted to screen large numbers of small molecule modulators of protein-protein interactions. They generated and evaluated 2 different luciferase reporter gene systems for YTH interactions, a Gal4 responsive firefly luciferase reporter gene and a Gal4 responsive Renilla luciferase reporter gene. Both the firefly and Renilla luciferase reporter genes demonstrated a 40- to 50-fold increase in luminescence in strains expressing interacting YTH fusion proteins versus negative control strains. Because the firefly and Renilla luciferase proteins have different substrate specificity, the assays were multiplexed. The multiplexed luciferase-based YTH platform adds speed, sensitivity, simplicity, quantification, and efficiency to YTH high-throughput applications and therefore greatly facilitates the identification of small molecule modulators of protein-protein interactions as tools or potential leads for drug discovery efforts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14711393     DOI: 10.1177/1087057103258287

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  7 in total

1.  Allosteric inhibition of the regulator of G protein signaling-Galpha protein-protein interaction by CCG-4986.

Authors:  David L Roman; Levi L Blazer; C Aaron Monroy; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2010-06-07       Impact factor: 4.436

Review 2.  Neurobiological applications of small molecule screening.

Authors:  Andras Bauer; Brent Stockwell
Journal:  Chem Rev       Date:  2008-05-01       Impact factor: 60.622

Review 3.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

Review 4.  Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials.

Authors:  Joseph B O'Brien; Joshua C Wilkinson; David L Roman
Journal:  J Biol Chem       Date:  2019-10-21       Impact factor: 5.157

5.  Polyplexed flow cytometry protein interaction assay: a novel high-throughput screening paradigm for RGS protein inhibitors.

Authors:  David L Roman; Shodai Ota; Richard R Neubig
Journal:  J Biomol Screen       Date:  2009-06-16

6.  RGS17: an emerging therapeutic target for lung and prostate cancers.

Authors:  Christopher R Bodle; Duncan I Mackie; David L Roman
Journal:  Future Med Chem       Date:  2013-06       Impact factor: 3.808

7.  High-throughput screening for growth inhibitors using a yeast model of familial paraganglioma.

Authors:  Irina Bancos; John Paul Bida; Defeng Tian; Mary Bundrick; Kristen John; Molly Nelson Holte; Yeng F Her; Debra Evans; Dyana T Saenz; Eric M Poeschla; Derek Hook; Gunda Georg; L James Maher
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.